BG Medicine (BGMD) Short Interest Ratio & Short Volume

Short interest is the volume of BG Medicine shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 100 shares of BGMD short. Learn More on BG Medicine's current short interest.

Here is how the short interest of companies compare to BG Medicine: Thermo Fisher Scientific Inc. (0.98%), Agilent Technologies, Inc. (1.08%), Mettler-Toledo International, Inc. (3.33%), Waters Corporation (4.01%), Illumina, Inc. (5.16%), Bio-Techne Corp (4.21%), Charles River Laboratories International, Inc. (4.50%), Bio-Rad Laboratories, Inc. (5.01%), Bruker Corporation (9.05%), Pacific Biosciences of California, Inc. (14.30%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

Short selling BGMD is an investing strategy that aims to generate trading profit from BG Medicine as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for BG Medicine occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BGMD, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BGMD, twice per month. The most recent reporting period available is July, 31 2025.